---
$id: https://graph.org.ai/products/commodity/51182046
$type: Product
source: UNSPSC
code: "51182046"
title: "Roxibolone"
class: "51182000"
classTitle: "Androgens and androgen inhibitors"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Roxibolone

**UNSPSC Code**: 51182046
**Class**: [Androgens and androgen inhibitors](Androgens and androgen inhibitors.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anabolic steroid with the molecular formula C21H28O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3R7NLP419C, chemically known as 11beta,17beta-dihydroxy-17-methyl-3-oxoandrosta-1,4-diene-2-carboxylic acid but generally known as roxibolone, which bears US NIH Compound Identifier 68795. European Medicines Agency schedules Roxibolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10397MIG. The term ROXIBOLONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). ROXIBOLONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule roxibolone under HS 29372900 and SITC 54153. As of Q4 2014, ROXIBOLONE remains the US FDA Preferred Term for this commodity. Roxibolone bears US NLM identifiers UMLS ID C0073602 and NCI Concept Code C74110. SMILES: OC1(C2(C(C3C(C(O)C2)C2(C(=CC(=O)C(=C2)C(=O)O)CC3)C)CC1)C)C.

